会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • METHOD FOR DETERMINING AN ACTIVE INGREDIENT DOSAGE
    • 方法确定活性剂量
    • WO2005033334A3
    • 2005-09-29
    • PCT/EP2004010560
    • 2004-09-21
    • BAYER TECHNOLOGY SERVICES GMBHSCHMITT WALTERWILLMANN STEFANDIESSEL EDGARDORN INGMARBURMEISTER JENS
    • SCHMITT WALTERWILLMANN STEFANDIESSEL EDGARDORN INGMARBURMEISTER JENS
    • G06F19/18G06Q50/24G06F19/00
    • G06F19/18G06Q50/24
    • The invention relates to a method for determining the dosage of at least one active ingredient based on a genetic analysis. The method comprises the following steps: a) analysis (101) of specific genetic sequences, using a genetic sequence-specific analysis device, in particular a sequence-specific sensor, or determination of the expression of proteins, either by RNA transcription using quantitative RNA-specific identification methods or by the direct measurement of the protein expression by a protein analysis device; b) assignment of the genetic sequences to physiological functions of the human or animal body, in particular to those physiological functions that influence the decomposition, absorption, release or distribution behaviour of the active ingredient in the body; c) transmission of the genetic and assignment data to a physiology-based pharmacokinetic model (PBPK model) (108); d) input of active ingredient-specific data into the PBPK model (108); e) input of characteristic patient data, optionally from direct measurements on the body; f) calculation of physiological influence parameters that are required for the PBPK model from the patient data, using information contained in the knowledge database and transmission of said parameters to the PBPK model (108); g) calculation of the individual dose from the data in steps c), d) and f), using the PBPK model (108).
    • 一种用于确定至少一种活性成分的基于描述的遗传分析的剂量方法。 该方法包括以下步骤:使用基因序列特异性分析器具中的)特定的基因序列的分析(101),特别是序列特异性的传感器,或测定蛋白质的任一上通过定量特定RNA的检测方法或直接测量RNA转录的表达 通过蛋白质分析仪b蛋白表达)具有基因序列与人体或动物体的生理功能,特别是影响记录的降解那些生理功能的分配,以传送或在药物在体内,c中的分配行为 )遗传和分配数据到基于生理学-药代动力学模型的公开内容(PBPK)模型(108)中,d)从直接在PBPK模型(108)的特征的患者数据物质,e)输入,特定药物的数据的输入可能 身体的测量,F)贝雷 使用包含在知识数据库中的信息所必需的来自患者的数据PBPK模型生理影响参数tatements和传递参数到PBPK模型(108)中,g)从所述数据中的单个剂量的计算的步骤c)之后,D )和f)使用所述PBPK模型(108)。